SCF synergizes with Epo via Epo receptor (p)y-dependent and -independent routes, selectively enhances Epo/Jak2/STAT5-dependent bclx & bcl2 gene transcription, and is the primary activator of Erks.

Conference Paper

Authors

  • Wojchowski, Don
  • Gieger, JN
  • Pircher, TJ
  • Gregory, RC
  • Miller, CP
  • Zhang, D
  • Panek, LB

    • Status

    Publication Date

  • November 15, 1999

    • Has Subject Area

    Published In

  • Blood  Journal

    • Start Page

  • 152B

    • End Page

  • 152B

    • Volume

  • 94

    • Issue

  • 10